首页> 美国卫生研究院文献>Iranian Journal of Cancer Prevention >Fertility Preservation Among the Cancer Patients by Ovarian Tissue Cryopreservation Transplantation and Follicular Development
【2h】

Fertility Preservation Among the Cancer Patients by Ovarian Tissue Cryopreservation Transplantation and Follicular Development

机译:通过卵巢组织冷冻保存移植和卵泡发育来保存癌症患者的生育力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ovarian tissue freezing or cryopreservation might be the only acceptable method for preserving the young women fertility, before radiotherapy or chemotherapy. This technology might be used for patients with recurrent ovarian cysts or endometriosis, without ovarian stimulation. Many efforts have made to improve cryopreservation conditions that should be seriously considered for cancer patients. Vitrification is a process which prevents ovarian tissue from cryo damage, then preserves cell viability. Both methods have used for evaluating not only the follicular development, but also the fertility after freezing and thawing. In this manuscript, we have discussed the techniques of ovarian tissue vitrification, then graft and maturation or follicular development is also mentioned.
机译:在放疗或化疗之前,卵巢组织冷冻或冷冻保存可能是保持年轻女性生育力的唯一可接受的方法。该技术可用于没有卵巢刺激的复发性卵巢囊肿或子宫内膜异位患者。已经做出了许多努力来改善对于癌症患者应认真考虑的冷冻保存条件。玻璃化是防止卵巢组织受到冷冻损伤,然后保持细胞活力的过程。两种方法不仅用于评估卵泡发育,还用于评估冷冻和解冻后的生育能力。在本手稿中,我们讨论了卵巢组织玻璃化技术,然后还提到了移植和成熟或卵泡发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号